{"name":"OpusPoint Partners","permalink":"opuspoint-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/opuspoint-partners","homepage_url":"http://www.opuspointpartners.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"212.554.4351","description":"capital management company","email_address":"jb@opuspointpartners.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Sun Apr 12 19:31:08 UTC 2009","updated_at":"Fri Oct 08 06:47:13 UTC 2010","overview":"<p>Opus Partners&#8217; managing member, Daryl Sakol, is committed to providing the most professional guidance during a seller&#8217;s divestiture. Mr. Sakol offers a historical perspective as a former seller, a former buyer and now as an intermediary. This allows sellers to benefit from Opus Partners&#8217; many years of transaction experience. &#8220;We understand what motivates, excites and concerns buyers, and recognize the areas critical to maximize valuation for sellers,&#8221; Mr. Sakol comments.</p>\n\n<p>Prior to forming Opus Partners, Mr. Sakol was associated with Affinity Ventures, a national mergers and acquisitions intermediary firm. At Affinity Ventures, Mr. Sakol was responsible for successfully completing a multitude of transactions for sellers of post-acute healthcare companies. Mr. Sakol also served as vice president of mergers and acquisitions for Home Medical of America, Inc., a national home medical equipment company. During his tenure, the company grew revenue through acquisitions from $30 million to $500 million. In 1988 he founded and served as president and CEO of National Rehab of Florida, Inc., a provider of specialty orthopedic home rehabilitation equipment.</p>","image":{"available_sizes":[[[149,69],"assets/images/resized/0006/1685/61685v1-max-150x150.jpg"],[[149,69],"assets/images/resized/0006/1685/61685v1-max-250x250.jpg"],[[149,69],"assets/images/resized/0006/1685/61685v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"","address2":"","zip_code":"","city":"New York","state_code":"NY","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.pehub.com/36508/vcs-pipe-435-million-to-sunesis-pharma/","source_description":"VCs PIPE $43.5 Million to Sunesis Pharma","raised_amount":43500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":7,"company":{"name":"Sunesis Pharmaceuticals","permalink":"sunesis-pharmaceuticals","image":{"available_sizes":[[[133,75],"assets/images/resized/0004/0936/40936v1-max-150x150.png"],[[133,75],"assets/images/resized/0004/0936/40936v1-max-250x250.png"],[[133,75],"assets/images/resized/0004/0936/40936v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.dorbiopharma.com/news.aspx?titleId=351","source_description":"Soligenix Announces Private Equity Financing of $5.16 Million with its Partner Sigma-Tau and other Institutional Investors","raised_amount":5160000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":16,"company":{"name":"Soligenix","permalink":"soligenix","image":{"available_sizes":[[[150,42],"assets/images/resized/0009/2621/92621v1-max-150x150.jpg"],[[250,70],"assets/images/resized/0009/2621/92621v1-max-250x250.jpg"],[[357,100],"assets/images/resized/0009/2621/92621v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}